Disc bulging. Intervertebral disc disorders with radiculopathy, lumbar region
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with lumbar disc herniation confirmed by an orthopedic specialist Consent to enter the study Absence of Cardiac disease (due to the possibility of complications of celecoxib consumption in coronary artery disease patients) Absence of gastrointestinal disease(like peptic ulcer disease) Absence of Mental Disorders related to water (like phobias)
Exclusion criteria
Exclusion criteria: Hypersensitivity to naproxen or celecoxib that patients can not use any of these two drugs.
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Daily quality of life score based on Oswestry low back pain disability questionnaire. Timepoint: En At the beginning of the intervention and 3 to 6 months after hydrotherapy and medication. Method of measurement: The Oswestry low back pain disability questionnaire. | — |
Primary
| Measure | Time frame |
|---|---|
| Back and lower limb pain score in patients with lumbar disc herniation based on Visual Analogue Scale. Timepoint: At the beginning of the intervention and 3 to 6 months after hydrotherapy and medication. Method of measurement: Visual Analogue Scale questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Ahvaz University of Medical Sciences